1. Home
  2. Live Updates
  3. National medical products administration on

Live Breaking News & Updates on National medical products administration on

Stay informed with the latest breaking news from National medical products administration on on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in National medical products administration on and stay connected to the pulse of your community

The U.S. FDA Approved the Phase I/II Clinical Trial Application to Evaluate LBL-033, An Anti-MUC16/CD3 Bispecific Antibody Developed by Leads Biolabs, in Advanced Solid Tumors Including Ovarian Cancer

/PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as "Leads Biolabs" or "Company") today announces that the phase I/II clinical trial...

China , Nanjing , Jiangsu , United-states , Charles-cai , National-medical-products-administration-on , Biolabs-or-company , Biolabs-co-ltd , Drug-administration , Sun-yat-sen-university-cancer-center , Chief-medical-officer , Leads-biolabs

China's first home-grown mRNA COVID vaccine rolled out in Hebei

China's first home-grown mRNA COVID vaccine rolled out in Hebei
globalsecurity.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalsecurity.org Daily Mail and Mail on Sunday newspapers.

Peking , Beijing , China , Guangzhou , Guangdong , Hebei , Jilin , Zeng-guang , Chinese , Wang-guangfa , Sina-weibo , Zhuang-shilihe

China's first home-grown mRNA COVID vaccine rolled out in Hebei

China's first domestically developed mRNA vaccine for COVID-19 was initially put into use in Shijiazhuang, North China's Hebei Province on Sunday.

Zeng-guang , Guangdong , China , Hebei , Jilin , Guangzhou , Peking , Beijing , Chinese , Zhuang-shilihe , Wang-guangfa , Sina-weibo

Sinopharm wins approval for inhaled Omicron antibody trials

Chinese drugmaker Sinopharm said on Monday it has obtained approval to conduct clinical trials of an inhaled monoclonal antibody against the novel coronavirus, a potentially significant weapon against the dominant Omicron variant.

Hangzhou , Zhejiang , China , Chinese , National-medical-products-administration-on , China-national-biotech-group , Battle-against-novel , National-biotech-group , National-medical-products-administration ,

Simcere Receives FDA Clearance of Investigational New Drug Application (IND) for Bi-functional Fusion Protein, SIM0237

/PRNewswire/ -- Simcere Pharmaceutical Group (2096.HK), an innovative global pharmaceutical company, today announced that the U.S. Food and Drug Administration...

China , Boston , Massachusetts , United-states , Nanjing , Jiangsu , Bijoyesh-mookerjee , Prnewswire-simcere-pharmaceutical-group , Simcere-pharmaceutical-group , National-medical-products-administration-on , Drug-administration , Pharmaceutical-group

China Expands HPV Vaccines Age, but Supply Concerns Remain

Many women have complained of a lack of access to the shots targeting nine virus strains due to limited stock and a high demand.

China , Henan , United-states , Shenzhen , Guangdong , Zhengzhou , Chinese , American , Merck-gardasil , National-medical-products-administration-on , National-medical-products-administration , Sixth-tone

Broncus (02216.HK) announced interim results

/PRNewswire/ -- On August 30, 2022, Broncus (02216.HK), the leader in the field of interventional pulmonology in China, reported its interim result for the six...

Germany , Australia , Japan , United-states , United-kingdom , Israel , China , Beijing , Liaoning , Guangdong , Jilin , France

Clinical trial volunteers receive China's inactivated vaccines against Omicron variants in Hangzhou, China-Xinhua

Clinical trial volunteers receive China's inactivated vaccines against Omicron variants in Hangzhou, China-

China , Zhejiang , Hangzhou , China-national-biotec-group , National-medical-products-administration-on , Xinhua , Zhejiang-province , National-medical-products-administration , Variants , Clinical , Inactivated

World's 1st Omicron-specific inactivated vaccine administered in China's Hangzhou

The first dose of COVID-19 inactivated vaccine specifically against the Omicron variant was administered on Sunday during a clinical trial in Hangzhou, East China’s Zhejiang Province, bringing hope to people in the regions hit by the highly transmissible variant.

China , Zhejiang , Hangzhou , Chinese , Li-lanjuan , Zheng-zhongwei , National-health-commission , National-medical-products-administration-on , East-china , Zhejiang-province , National-medical-products-administration , Omicron

UAE: 6,243 vaccine doses administered in 24 hours

The total doses administered now stand at 24.7 million

China , Ministry-of-health , Dubayy , United-arab-emirates , Chinese , China-national-biotec-group , National-medical-products-administration-on , Drug-administration , Xinhua , National-medical-products-administration , Vaccine